SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EYES (Vision Twenty-One, Inc.) -- Ignore unavailable to you. Want to Upgrade?


To: goordo who wrote (17)4/9/1998 9:31:00 AM
From: Wally Mastroly  Read Replies (1) | Respond to of 129
 
EYES Announces Completion of Certain Acquisitions:

"LARGO, Fla., April 9 /PRNewswire/ -- Vision Twenty-One, Inc. (Nasdaq: EYES - news), an eye care management company, today announced the completion of four transactions consisting of two optometric chains with a total of 35 locations, a vision benefit management company marketed to small employer groups, and an optical laboratory. Consideration paid by the company for the transactions was approximately $22.4 million consisting of $5.9 million in cash and approximately 1.6 million shares of Vision Twenty-One stock. The final consideration is subject to certain adjustments. On a pro forma basis, these acquisitions are accretive to earnings..."

biz.yahoo.com